Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0TUZRP
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
BL-M002A2
|
|||||
| Synonyms |
BL-B002A2; BL-M002; BL M002; BLM002
Click to Show/Hide
|
|||||
| Organization |
Systimmune, Inc.; Sichuan Baili Pharmaceutical Co., Ltd.
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 1 Indication(s)
Glioblastoma [ICD11:2A00]
Clinical candidate
|
|||||
| Antibody Name |
Undisclosed
|
Antigen Name |
Undisclosed
|
|||
| Payload Name |
Undisclosed
|
|||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.